Hypoxia-induced inflammation in the lung: a potential therapeutic target in acute lung injury? (Q38054037)

27 August 2017

title

Hypoxia-induced inflammation in the lung: a potential therapeutic target in acute lung injury? (English)

1 reference

27 August 2017

0 references

0 references

Stephen Fröhlich

1

1 reference

27 August 2017

John Boylan

series ordinal

2

1 reference

27 August 2017

Paul McLoughlin

series ordinal

3

1 reference

27 August 2017

publication date

18 October 2012

1 reference

American Journal of Respiratory Cell and Molecular Biology

27 August 2017

published in

1 reference

27 August 2017

volume

48

1 reference

27 August 2017

issue

3

1 reference

27 August 2017

page(s)

271-279

1 reference

Alveolar hypoxia-induced systemic inflammation: what low PO(2) does and does not do.

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

21 January 2018

Hypoxia and inflammation

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Involvement of a ferroprotein sensor in hypoxia-mediated inhibition of neutrophil apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

A2B adenosine receptor dampens hypoxia-induced vascular leak

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Sterile inflammation: sensing and reacting to damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Ischemia and reperfusion--from mechanism to translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

HIF and the lung: role of hypoxia-inducible factors in pulmonary development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

NF-kappaB plays a key role in hypoxia-inducible factor-1-regulated erythropoietin gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Microtubule disruption utilizes an NFkappa B-dependent pathway to stabilize HIF-1alpha protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Tumor necrosis factor-alpha causes accumulation of a ubiquitinated form of hypoxia inducible factor-1alpha through a nuclear factor-kappaB-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Hepatocyte growth factor-activated NF-kappaB regulates HIF-1 activity and ODC expression, implicated in survival, differently in different carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Hypoxia-induced IL-18 increases hypoxia-inducible factor-1alpha expression through a Rac1-dependent NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Reactive oxygen species-generating mitochondrial DNA mutation up-regulates hypoxia-inducible factor-1alpha gene transcription via phosphatidylinositol 3-kinase-Akt/protein kinase C/histone deacetylase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH)

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Acute hypoxia induces HIF-independent monocyte adhesion to endothelial cells through increased intercellular adhesion molecule-1 expression: the role of hypoxic inhibition of prolyl hydroxylase activity for the induction of NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Loss of the oxygen sensor PHD3 enhances the innate immune response to abdominal sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

MicroRNA-210: a unique and pleiotropic hypoxamir

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Hypoxia potentiates microRNA-mediated gene silencing through posttranslational modification of Argonaute2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Translational control of collagen prolyl 4-hydroxylase-alpha(I) gene expression under hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Microvascular and tissue oxygen gradients in the rat mesentery

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

PULMONARY VASOCONSTRICTION IN RESPONSE TO PRECAPILLARY HYPOXEMIA

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Studies in hypothermia. VII. Anaphylactoid reaction to low-molecular-weight dextran in hypothermic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

The physiologic basis of high-altitude diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

FIZZ1/RELMα, a Novel Hypoxia-Induced Mitogenic Factor in Lung With Vasoconstrictive and Angiogenic Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMalpha) induces the vascular and hemodynamic changes of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Gremlin plays a key role in the pathogenesis of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

CXCR7 functions as a scavenger for CXCL12 and CXCL11

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Chronic hypoxia causes angiogenesis in addition to remodelling in the adult rat pulmonary circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Hypoxia/Hypoxemia-Induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Inflammatory cytokines in BAL fluid and pulmonary hemodynamics in high-altitude pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

The systemic inflammation of alveolar hypoxia is initiated by alveolar macrophage-borne mediator(s)

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Monocyte Chemoattractant Protein–1 Released from Alveolar Macrophages Mediates the Systemic Inflammation of Acute Alveolar Hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Alveolar macrophages are necessary for the systemic inflammation of acute alveolar hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

L-Arginine promotes angiogenesis in the chronically hypoxic lung: a novel mechanism ameliorating pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Hypoxia selectively activates the CREB family of transcription factors in the in vivo lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

The von Hippel-Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Transcriptional regulation by the phosphorylation-dependent factor CREB

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Cyclic AMP response element-binding protein prevents endothelial permeability increase through transcriptional controlling p190RhoGAP expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

An intact canonical NF-κB pathway is required for inflammatory gene expression in response to hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Role of oxidative stress and NFkB in hypoxia-induced pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

miR-210 has an antiapoptotic effect in pulmonary artery smooth muscle cells during hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

The acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Influence of positioning on ventilation-perfusion relationships in severe adult respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Permissive hypercapnia impairs pulmonary gas exchange in the acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Pulmonary vascular dysfunction is associated with poor outcomes in patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

Anatomical and functional intrapulmonary shunt in acute respiratory distress syndrome*

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0137TR

21 January 2018

Identifiers

DOI

10.1165/RCMB.2012-0137TR

1 reference

27 August 2017

1 reference